CAT3	13a-(S)-3-pivaloyloxyl-6,7-dimethoxyphenanthro(9,10-b)-indolizidine
PF403	13a-(S)-3-hydroxyl-6,7-dimethoxyphenanthro(9,10-b)-indolizidine
GBM	Glioblastoma multiforme
TMZ	Temozolomide
SLN	Solid lipid nanoparticles
MDCK-MDR1	Madin-Darby canine kidney cells transfected with the human MDR1 gene
SD	Sprague-Dawley
NMR	Nuclear magnetic resonance
TMS	Tetramethylsilane
DL	Drug loading
EE	Encapsulation efficiency
OA	Oleic acid
OA-CAT3	Oleic acid and CAT3 conjugate
OA-CAT3-SLN	OA-CAT3 loaded SLN
CAT3-SLN	With the same composition and contents to the OA-CAT3-SLN except the preparation of OA-CAT3 in advance
DSC	Differential scanning calorimetry
FTIR	Fourier transform infrared spectroscopy
API	Active pharmaceutical ingredient
PVDF	Polyvinylidene fluoride
TEER	Transepithelial electrical resistance
DI	Deionized
PDI	Polydispersity index
HBSS	Hanks’ balanced salt solution
AP	Apical side
BL	Basolateral
LC-MS/MS	Liquid chromatography-mass spectrometry
P app	Apparent permeability coefficient
HPLC	High-performance liquid chromatography
C6-luc	Luciferase-expressing C6 cells
DAPI	4′,6-diamidino-2-phenylindole
LSCM	laser scanning confocal microscopy
MTT	3-(4, 5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide
MCYP	Methyl-β-Cyclodextrin
PBS	Phosphate-buffered saline
Cou-6	Fluorescent Coumarin 6
ISTD	Internal standard
DAS	Drug and Statistics